Cancer is the leading cause of death in patients 80 years of age. There are more than 1.5 million new cases of cancer from any source in the U.S. yearly. Lung cancer, along with being the number one cancer killer in men in the past 10 years, is also the number one cancer killer in women, surpassing breast cancer previously in that category.

In 2010 there were 81,000 deaths in men, representing 31% of all male cancer deaths and 76,000 deaths in women, representing 26% of all female cancer deaths. In fact death from lung cancer surpasses deaths from breast, colon, and prostate cancer combined.

Healthy Eating.

The importance of proper dietary habits, pH balancing, and proper supplementation cannot be overemphasized as a major weapon which is under the direct control of the patients themselves.

With the advent of chemosensitivity testing, especially from the Good Gene Laboratory in Houston, Texas, we are now able to pinpoint specific recommendations for each patient based on genetic decoding.  These include a list of supplements which will provide the most ammunition to effect the deaths of the "mother stem cells", as well as to fortify the immune system.

 In addition, such recommendations as to whether "soy" products should be included in diets is uncovered and often recommended by these tests.  Soy is a phytoestrogen and as such has been controversial in its use in both breast and prostate cancers.

Rationing Oncology Care?

As a cost saving maneuver to cut the cost of entitlement medical costs of Medicare, Medicaid and its soon to be implemented “Obamacare”, subtle rationing measures are already here. Teaching courses for primary care physicians are now telling attendees that if patients are over 50/60/70 there are certain cancer screening tests that are not cost-effective and not indicated. Here are some examples in the Big 4 Cancers.

In Breast Cancer, yearly mammograms after 50 are being reduced to every two years until age 70 to 75, when any screening is being discouraged. Unbelievably Breast-Self- Examinations (BSE) are being down played as of little value even in women over 40 years of age. Also safer diagnostic procedures, which give less radiation exposure such as ultra sounds and MRI’s because of their expense are being discouraged.

Integrative Oncology Pursuit of the “CURE”

Chemosensitivity testing on patients’ whole blood samples, to harvest circulating tumor cells (CTC’S), is one of the most important and successful tools used in my medical practice but literally unknown and undiscovered to most conventional oncologists. Extremely Hi-Tech genetic laboratories only available in Germany and Greece do the testing. Now the chemosensitivity testing can be done in the United States. The Korean based laboratory, “Goodgen” is operating out of Houston, Texas. Special handling and packaging kits available through my office as in-patients only.